For the first time, researchers have shown that self-assembled phosphorus chains can host genuinely one-dimensional electron ...

SpaceX has already shifted focus to building a self-growing city on the Moon, as we can potentially achieve that in less than ...

Using ideas borrowed from topological photonics, researchers in Singapore, France and the US have designed a compact antenna ...

Since the dawn of the computer age, researchers have wrestled with two persistent challenges: how to store ever-increasing ...

Earth observation data underpin climate science, disaster response, and environmental policy, yet inconsistent grid ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

Advancing neural interfaces requires implantable devices capable of long-term electrical and chemical monitoring. “All”-glassy carbon (GC) microelectrode arrays (MEAs), in which both electrodes and ...

The selloff in Array Digital Infrastructure's fixed-income securities post-UScellular sale is overdone, creating an attractive entry point. AD's 5.50% Senior Notes now yield 8.05% and trade at a 31.6% ...